| Literature DB >> 24729758 |
Olivia I Okereke1, Jeffrey M Lyness1, Francis E Lotrich1, Charles F Reynolds1.
Abstract
Depression is a leading cause of disease burden, disability and distress for millions of older adults. Thus, prevention of late-life depression is a priority research area. This article addresses the science of late-life depression prevention with the following: 1) an introduction to the Institute of Medicine framework of universal, selective and indicated prevention as it pertains to late-life depression, with particular attention to successes of indicated and selective prevention in primary care; 2) a discussion of how biomarkers can be integrated into prevention research, using interferon-alpha-induced depression as a model; 3) an outline for expansion of prevention to non-specialist care delivery systems in Low and Middle Income Countries - thus, extending the reach of current successful approaches; 4) a description of a novel approach to simultaneous testing of universal, selective and indicated prevention in late-life depression, with emphasis on study design features required to achieve practical, scalable tests of health impact.Entities:
Year: 2013 PMID: 24729758 PMCID: PMC3982610 DOI: 10.1176/appi.focus.11.1.22
Source DB: PubMed Journal: Focus (Am Psychiatr Publ) ISSN: 1541-4094